GENERAL APPLICATION OF THE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE) GUIDANCE FOR ACTIVE SURVEILLANCE FOR MEN WITH PROSTATE CANCER IS NOT APPROPRIATE IN UNSCREENED POPULATIONS

Authors


No abstract is available for this article.

Ancillary